Health Care & Life Sciences » Pharmaceuticals | Hwail Pharmaceutical Co. Ltd.

Hwail Pharmaceutical Co. Ltd.

Hwail Pharmaceutical Co. Ltd.
Stock Exchange Korea Exchange
EPS
KRW366
Market Cap
KRW114.86 B
Shares Outstanding
14.41 M
Public Float
8.8 M

Profile

Address
57 Jeyakgongdan 3-gil
Hwaseong GY 18622
Korea, Republic Of
Employees -
Website http://www.hwail.com
Updated 09/14/2018
HWAIL PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following businesses: Pharmaceutical Raw Material, Cephalosporin Antibiotic, Functional Health Food Ingredient. Its products include antitussive expectorants, spasmolytic, stomach function modifier, anti-inflammatory and others.

Financials

View All

Joong-Myung Cho
Chairman & Co-Chief Executive Officer
Phil-Joon Park
President, Co-Chief Executive Officer & Director